Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Ovid Therapeutics Inc. (NASDAQ: OVID)

$14.48 USD -$0.09 (-0.62%)
Last Price $14.48
Net Change $-0.09 (-0.62%)
Bid $0
Ask Price $0
Open Price $14.62
Previous Close Price $14.57
High Price $14.9
Low Price $14.46
Number of Trades 173
Volume 22,000
Fifty Two Week High $15.93 (2017-05-18)
Fifty Two Week Low $12.08 (2017-05-05)
Average Daily Volume 49,207
Share Outstanding 24,600 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $0
Last Quarter EPS $
Market Capitalization $0.36B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 24,600
Inst. Shareholder % 0%
Annual Net Income $0B
TTM Net Profit Margin $100
1-Year Return 18.2%
3-Year Return 18.2%
5-Year Return 18.2%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio
Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company's product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved in developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States.

OVID News & Stock Updates